ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 28 filers reported holding ELEVATION ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,370,142 | $2,678,000 | 3.89% |
| Aisling Capital Management LP | 2,834,910 | $3,203,000 | 2.13% |
| venBio Partners LLC | 1,866,339 | $2,109,000 | 0.49% |
| Samsara BioCapital, LLC | 830,565 | $939,000 | 0.22% |
| TCG Crossover Management, LLC | 555,000 | $627,000 | 0.19% |
| Cormorant Asset Management, LP | 1,952,032 | $2,206,000 | 0.15% |
| CAXTON CORP | 68,297 | $77,000 | 0.14% |
| Sio Capital Management, LLC | 359,731 | $406,000 | 0.13% |
| BVF INC/IL | 2,312,200 | $2,613,000 | 0.11% |
| Marquette Asset Management, LLC | 38,951 | $44,000 | 0.01% |